Hammerson PLC
10 April 2002
Stock Exchange Announcement
On 3 April 2002 allocations of shares by way of the grant of nil cost options
were made, in accordance with the terms of the Deferred Share Plan, to executive
directors and senior executives. These options may be exercised after a period
of three years with the number of shares over which such options can be
exercised being dependent on the level of achievement of financial performance
targets over that period. The maximum number of shares over which an option can
be exercised in respect of the grant made on 3 April 2002 and the total maximum
number of shares in respect of this and the previous grants made in 2000 and
2001 by the following Executive Directors are as follow:
3.4.02 Total
R J G Richards 55,618 176,173
J A Bywater 32,818 105,729
P W B Cole 32,818 102,067
G Devaux 36,272 114,105
S R Melliss 42,318 131,511
For further information:
Stuart Haydon
Company Secretary
020 7887 1000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.